|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: Globocan 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamangar F and Dores GM: Defining
priorities to reduce cancer disparities in different geographic
regions of the world. J Clin Oncol. 24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern
Cooperative Oncology Group: Comparison of four chemotherapy
regimens for advanced non-small-cell lung cancer. N Engl J Med.
346:92–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Scagliotti GV, De Marinis F, Rinaldi M,
Crinò L, Gridelli C, Ricci S, Matano E, Boni C, Marangolo M, Failla
G, et al: Phase III randomized trial comparing three platinum-based
doublets in advanced non-small-cell lung cancer. J Clin Oncol.
20:4285–4291. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paik PK, Johnson ML, D'Angelo SP, Sima CS,
Ang D, Dogan S, Miller VA, Ladanyi M, Kris MG and Riely GJ: Driver
mutations determine survival in smokers and never-smokers with
stage IIIB/IV lung adenocarcinomas. Cancer. 118:5840–5847. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
An SJ, Chen ZH, Su J, Zhang XC, Zhong WZ,
Yang JJ, Zhou Q, Yang XN, Huang L, Guan JL, et al: Identification
of enriched driver gene alterations in subgroups of non-small cell
lung cancer patients based on histology and smoking status. PLoS
One. 7:e401092012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Beau-Faller M, Ruppert AM, Voegeli AC,
Neuville A, Meyer N, Guerin E, Legrain M, Mennecier B, Wihlm JM,
Massard G, et al: MET gene copy number in non-small cell lung
cancer: Molecular analysis in a targeted tyrosine kinase inhibitor
naive cohort. J Thorac Oncol. 3:331–339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bearz A, Passalacqua R, Alabiso O, Cinieri
S, Gridelli C, Cravesana C and Crinò L: First-line
bevacizumab-based therapy in advanced non-squamous non-small-cell
lung cancer: Analysis of the Italian patients enrolled in the SAiL
study. Clin Drug Investig. 32:755–760. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee RW and Huttner WB: Tyrosine-O-sulfated
proteins of PC12 pheochromocytoma cells and their sulfation by a
tyrosylprotein sulfotransferase. J Biol Chem. 258:11326–11334.
1983.PubMed/NCBI
|
|
11
|
Ouyang YB and Moore KL: Molecular cloning
and expression of human and mouse tyrosylprotein sulfotransferase-2
and a tyrosylprotein sulfotransferase homologue in Caenorhabditis
elegans. J Biol Chem. 273:24770–24774. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Beisswanger R, Corbeil D, Vannier C,
Thiele C, Dohrmann U, Kellner R, Ashman K, Niehrs C and Huttner WB:
Existence of distinct tyrosylprotein sulfotransferase genes:
Molecular characterization of tyrosylprotein sulfotransferase-2.
Proc Natl Acad Sci USA. 95:11134–11139. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moore KL: The biology and enzymology of
protein tyrosine O-sulfation. J Biol Chem. 278:24243–24246. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mishiro E, Sakakibara Y, Liu MC and Suiko
M: Differential enzymatic characteristics and tissue-specific
expression of human TPST-1 and TPST-2. J Biochem. 140:731–737.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao H, Langerod A, Ji Y, Nowels KW and
Nesland JM: Different gene expression patterns in invasive lobular
and ductal carcinomas of the breast. Mol Biol Cell. 15:2523–2536.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Toruner GA, Ulger C, Alkan M, Galante AT,
Rinaggio J, Wilk R, Tian B, Soteropoulos P, Hameed MR, Schwalb MN
and Dermody JJ: Association between gene expression profile and
tumor invasion in oral squamous cell carcinoma. Cancer Genet
Cytogenet. 154:27–35. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barretina J, Taylor BS, Banerji S, Ramos
AH, Lagos-Quintana M, Decarolis PL, Shah K, Socci ND, Weir BA, Ho
A, et al: Subtype-specific genomic alterations define new targets
for soft-tissue sarcoma therapy. Nat Genet. 42:715–721. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu J, Deng X, Tang M, Li L, Xiao L, Yang
L, Zhong J, Bode AM, Dong Z, Tao Y and Cao Y: Tyrosylprotein
sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4
are induced by Epstein-Barr virus encoded latent membrane protein 1
and associated with the metastatic potential of human
nasopharyngeal carcinoma. PLoS One. 8:e561142013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Landi L, Minuti G, D'Incecco A and
Cappuzzo F: Targeting c-MET in the battle against advanced
nonsmall-cell lung cancer. Curr Opin Oncol. 25:130–136. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Di Renzo MF, Olivero M, Ferro S, Prat M,
Bongarzone I, Pilotti S, Belfiore A, Costantino A, Vigneri R and
Pierotti MA: Overexpression of the c-MET/HGF receptor gene in human
thyroid carcinomas. Oncogene. 7:2549–2553. 1992.PubMed/NCBI
|
|
21
|
Natali PG, Nicotra MR, Di Renzo MF, Prat
M, Bigotti A, Cavaliere R and Comoglio PM: Expression of the
c-Met/HGF receptor in human melanocytic neoplasms: Demonstration of
the relationship to malignant melanoma tumour progression. Br J
Cancer. 68:746–750. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rami-Porta R, Crowley JJ and Goldstraw P:
The revised TNM staging system for lung cancer. Ann Thorac
Cardiovasc Surg. 15:4–9. 2009.PubMed/NCBI
|
|
23
|
Jiang J, Zhu Y, Wu C, Shen Y, Wei W, Chen
L, Zheng X, Sun J, Lu B and Zhang X: Tumor expression of B7-H4
predicts poor survival of patients suffering from gastric cancer.
Cancer Immunol Immunother. 59:1707–1714. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hamamoto J, Soejima K, Yoda S, Naoki K,
Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Yasuda H, et al:
Identification of microRNAs differentially expressed between lung
squamous cell carcinoma and lung adenocarcinoma. Mol Med Rep.
8:456–462. 2013.PubMed/NCBI
|
|
25
|
Mishiro E, Liu MY, Sakakibara Y, Suiko M
and Liu MC: Zebrafish tyrosylprotein sulfotransferase: Molecular
cloning, expression and functional characterization. Biochem Cell
Biol. 82:295–303. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Westmuckett AD, Hoffhines AJ, Borghei A
and Moore KL: Early postnatal pulmonary failure and primary
hypothyroidism in mice with combined TPST-1 and TPST-2 deficiency.
Gen Comp Endocrinol. 156:145–153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Komori R, Amano Y, Ogawa-Ohnishi M and
Matsubayashi Y: Identification of tyrosylprotein sulfotransferase
in Arabidopsis. Proc Natl Acad Sci USA. 106:15067–15072. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sherry DM: Lack of protein-tyrosine
sulfation disrupts photoreceptor outer segment morphogenesis,
retinal function and retinal anatomy. Eur J Neurosci. 32:1461–1472.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cooper CS, Park M, Blair DG, Tainsky MA,
Huebner K, Croce CM and Vande Woude GF: Molecular cloning of a new
transforming gene from a chemically transformed human cell line.
Nature. 311:29–33. 1984. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamamoto S, Tsuda H, Miyai K, Takano M,
Tamai S and Matsubara O: Gene amplification and protein
overexpression of MET are common events in ovarian clear-cell
adenocarcinoma: Their roles in tumor progression and
prognostication of the patient. Mod Pathol. 24:1146–1155. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun YL, Liu WD, Ma GY, Gao DW, Jiang YZ,
Liu Q and Du JJ: Expression of HGF and Met in human tissues of
colorectal cancers: Biological and clinical implications for
synchronous liver metastasis. Int J Med Sci. 10:548–559. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Siemens H, Neumann J, Jackstadt R,
Mansmann U, Horst D, Kirchner T and Hermeking H: Detection of
miR-34a promoter methylation in combination with elevated
expression of c-Met and β-catenin predicts distant metastasis of
colon cancer. Clin Cancer Res. 19:710–720. 2013. View Article : Google Scholar
|
|
33
|
Patil MA, Lee SA, Macias E, Lam ET, Xu C,
Jones KD, Ho C, Rodriguez-Puebla M and Chen X: Role of cyclin DI as
a mediator of c-Met-and beta-catenin-induced hepatocarcinogenesis.
Cancer Res. 69:253–261. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jardim DL, de Melo Gagliato D, Falchook
GS, Janku F, Zinner R, Wheler JJ, Subbiah V, Piha-Paul SA, Fu S,
Murphy MB, et al: MET aberrations and c-MET inhibitors in patients
with gastric and esophageal cancers in a phase I unit. Oncotarget.
5:1837–1845. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun W, Ai T, Gao Y, Zhang Y, Cui J and
Song L: Expression and prognostic relevance of MET and phospho-BAD
in non-small cell lung cancer. Onco Targets. 6:1315–1323. 2013.
|
